Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (12)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Périodique
STOLTZ J. A. ; E. WOOD ; W. SMALL ; K. LI ; M. TYNDALL ; J. MONTANER ; T. KERR | 2007ENGLISH : Injection drug users (IDUs) are vulnerable to serious health complications resulting from unsafe injection practices. We examined whether the use of a supervised safer injection facility (SIF) promoted change in injecting practices a[...]Périodique
J. H. JAFFE ; M. GOSSOP ; M. TYNDALL ; R. E. MANN ; P. REUTER ; W. HAO ; D. WEATHERBURN ; J. P. CAULKINS ; L. DEGENHARDT ; W. HALL ; C. DAY ; P. DIETZE ; L. COLLINS ; POINTER S. | 2005Neuf commentaires sont proposés. Le premier, au regard des résultats de cette étude analyse un événement similaire survenu aux Etats-Unis en 1972/1973. Le deuxième s'intéresse aux conséquences du transfert de l'usage injectable d'héroïne vers l'[...]Périodique
B. FISHER ; S. BRISSETTE ; S. BROCHU ; J. BRUNEAU ; N. EL-GUEBALY ; L. NOEL ; J. REHM ; M. TYNDALL ; C. WILD ; MUN P. ; E. HAYDON ; D. BALIUNAS | 2004ENGLISH : Background: Drug overdose is a major cause of death and illness among illicit drug users. Previous research has indicated that most illicit drug users experience nonfatal overdoses and has suggested a variety of factors that are asso[...]Périodique
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
B. M. MATHERS ; L. DEGENHARDT ; B. PHILLIPS ; L. WIESSING ; M. HICKMAN ; S. A. STRATHDEE ; A. WODAK ; PANDA S. ; M. TYNDALL ; A. TOUFIK ; R. P. MATTICK | 2008ENGLISH : BACKGROUND: Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among peo[...]Périodique
C. L. MILLER ; M. TYNDALL ; P. SPITTAL ; K. LI ; LALIBERTE N. ; M. T. SCHECHTER | 2002ENGLISH : Youth are important with respect to HIV/AIDS, not only because they are at risk of infection, but it is during this period that many behaviour patterns are established that will affect their risk of infection in later life. We undert[...]Article : Périodique
T. KERR ; STOLTZ J. A. ; M. TYNDALL ; K. LI ; R. ZHANG ; J. MONTANER ; E. WOOD |Problem: Illicit use of injected drugs is linked with high rates of HIV infection and fatal overdose, as well as community concerns about public drug use. Supervised injecting facilities have been proposed as a potential solution, but fears have[...]
Article : Périodique
K. DEBECK ; T. KERR ; L. BIRD ; R. ZHANG ; D. MARSH ; M. TYNDALL ; J. MONTANER ; E. WOOD |Background Vancouver, Canada has a pilot supervised injecting facility (SIF), where individuals can inject pre-obtained drugs under the supervision of medical staff. There has been concern that the program may facilitate ongoing drug use and del[...]
Article : Périodique
W. SMALL ; J. SHOVELLER ; D. MOORE ; M. TYNDALL ; E. WOOD ; T. KERR |North America's first supervised injection facility (SIF) was established in Vancouver, Canada, in 2003. Although evaluation research has documented reductions in risk behavior among SIF users, there has been limited examination of the influence[...]
Article : Périodique
C. RUSSELL ; S. RUEDA ; R. ROOM ; M. TYNDALL ; B. FISCHER |Background: Cannabis use is common, and associated with adverse health outcomes. 'Routes of administration' (ROAs) for cannabis use have increasingly diversified, in part influenced by developments towards legalization. This paper sought to revi[...]![Safer injection facility use and syringe sharing in injection drug users ; Being realistic about benefits of supervised injecting facilities [Comment]](https://bdoc.ofdt.fr/img_cache/44439d2fb1c8474e922da2b3b0731cb8.png)
Article : Périodique
T. KERR ; M. TYNDALL ; K. LI ; J. MONTANER ; E. WOOD |Safer injection facilities provide medical supervision for illicit drug injections. We aimed to examine factors associated with syringe sharing in a community-recruited cohort of illicit injection drug users in a setting where such a facility ha[...]Périodique
C. L. MILLER ; K. J. CHAN ; A. PALEPU ; M. TYNDALL ; E. WOOD ; R. HOGG ; M. V. O'SHAUGHNESSY | 2001ENGLISH : Objective: To describe the sociodemographic characteristics and HIV and Hepatitis C prevalence among persons who died of a drug overdose in the Vancouver metropolis health region in 1998. Methods: A retrospective review was conducted[...]Article : Périodique
M. KRAJDEN ; D. A. COOK ; S. WONG ; A. YU ; Z. A. BUTT ; C. ROSSI ; M. DARVISHIAN ; M. ALVAREZ ; J. A. BUXTON ; M. TYNDALL ; N. Z. JANJUA |Background: Persons with hepatitis C virus (HCV) infection are at risk of mortality from both chronic liver disease and HCV acquisition risk activities. We compared causes of death among HCV positive and negative individuals to characterize cont[...]
